Market Overview

From Earlier: Mizuho Securities Downgrades Myriad Genetics, Inc. to Neutral, Lowers PT to $30.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for MYGN

DateFirmActionFromTo
Nov 2017Deutsche BankMaintainsHold
Nov 2017Morgan StanleyMaintainsUnderweight
Oct 2017Morgan StanleyMaintainsUnderweight

View More Analyst Ratings for MYGN
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (MYGN)

Partner Center